HC Wainwright & Co. Maintains Hookipa Pharma (HOOK) Buy Recommendation
Fintel reports that on August 11, 2023, HC Wainwright & Co. maintained coverage of Hookipa Pharma (NASDAQ:HOOK) with a Buy recommendation.
Trending
Symbol | Last Price | Change | % Change |
---|---|---|---|